Detalhe da pesquisa
1.
An introduction to the Marburg virus vaccine consortium, MARVAC.
PLoS Pathog
; 18(10): e1010805, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227853
2.
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
J Infect Dis
; 228(Suppl 7): S660-S670, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171813
3.
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
Nature
; 520(7549): 688-691, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853476
4.
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
J Virol
; 92(3)2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29142131
5.
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.
J Infect Dis
; 218(suppl_5): S582-S587, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29939296
6.
Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
J Virol
; 91(8)2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28148802
7.
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
J Infect Dis
; 212 Suppl 2: S443-51, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109675
8.
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
PLoS Negl Trop Dis
; 16(5): e0010433, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35622847
9.
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Vaccine
; 39(38): 5436-5441, 2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373117
10.
Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication.
J Virol
; 83(16): 8233-46, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19494020
11.
Immune correlates of postexposure vaccine protection against Marburg virus.
Sci Rep
; 10(1): 3071, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32080323
12.
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
Lancet Infect Dis
; 20(4): 455-466, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952923
13.
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
J Clin Invest
; 130(1): 539-551, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820871
14.
A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
Viral Immunol
; 20(3): 441-52, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17931114
15.
Measurement of apoptosis by DNA fragmentation.
Methods Mol Biol
; 282: 1-17, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15105553
16.
mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection.
Virology
; 452-453: 175-190, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24606695